Non-Current Assets
Equity securities
Merck & Co. Equity securities increased by 12.9% to $1.57B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.1%, from $1.03B to $1.57B. Over 5 years (FY 2020 to FY 2025), Equity securities shows a downward trend with a -4.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ2 2018
Last reportedQ1 2026May 4, 2026
How to read this metric
An increase reflects positive market performance of the underlying investments or additional capital deployment into equities.
Detailed definition
This represents the fair market value of the company's investment portfolio consisting of equity securities in other ent...
Peer comparison
Standard for companies with large corporate venture arms or significant treasury investment portfolios.
Metric ID:
ins_equity_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.58B | $1.92B | $1.65B | $1.40B | $1.53B | $1.33B | $1.28B | $1.59B | $1.52B | $1.75B | $764.00M | $908.00M | $1.03B | $984.00M | $920.00M | $1.03B | $1.18B | $1.55B | $1.39B | $1.57B |
| QoQ Change | — | +21.3% | -14.0% | -15.2% | +9.5% | -12.8% | -3.7% | +23.4% | -4.1% | +14.9% | -56.2% | +18.8% | +13.0% | -4.1% | -6.5% | +12.3% | +14.3% | +30.9% | -10.0% | +12.9% |
| YoY Change | — | — | — | — | -3.1% | -30.3% | -22.0% | +13.5% | -0.7% | +30.9% | -40.5% | -42.7% | -32.5% | -43.6% | +20.4% | +13.8% | +15.1% | +57.1% | +51.3% | +52.1% |
Range$764.00M – $1.92B
CAGR-0.1%
Avg YoY Growth+2.4%
Median YoY Growth+6.4%
Equity securities at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s equity securities?
- Merck & Co. (MRK) reported equity securities of $1.57B in Q1 2026.
- How has Merck & Co.'s equity securities changed year-over-year?
- Merck & Co.'s equity securities increased by 52.1% year-over-year, from $1.03B to $1.57B.
- What is the long-term trend for Merck & Co.'s equity securities?
- Over 5 years (2020 to 2025), Merck & Co.'s equity securities has grown at a -4.9% compound annual growth rate (CAGR), from $1.79B to $1.39B.
- What does equity securities mean?
- The current market value of the company's stock investments in other businesses.